Nyxoah SA
Develops hypoglossal neurostimulation therapy for Obstructive Sleep Apnea (OSA).
NYXH | BR
Overview
Corporate Details
- ISIN(s):
- BE0974358906
- LEI:
- 5493002O1ESKZ18OXR80
- Country:
- Belgium
- Address:
- Rue Edouard Belin 12, 1435 Mont-Saint-Guibert
- Website:
- https://www.nyxoah.com/
- Sector:
- Manufacturing
Description
Nyxoah SA is a medical technology company focused on the development and commercialization of solutions for Obstructive Sleep Apnea (OSA). The company's lead product is the Genio® system, a hypoglossal neurostimulation (HNS) therapy designed for patients with moderate to severe OSA. The system features a patient-centered, leadless, and battery-free implantable stimulator. It functions by providing bilateral stimulation to the hypoglossal nerve, which controls tongue muscles, to maintain an open airway during sleep.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-05-30 22:30 |
2025 05 30 PR Transparency notifications 2025 05 (Vestal Point) (ENG).pdf
|
English | 168.4 KB | ||
| 2025-05-30 22:30 |
2025 05 30 PR Transparency notifications 2025 05 (Vestal Point) (FR).pdf
|
French | 193.9 KB | ||
| 2025-05-23 22:30 |
2025 05 23 - Press release - Number of shares (ENG).pdf
|
English | 136.5 KB | ||
| 2025-05-23 22:30 |
2025 05 23 - Press release - Number of shares (FR).pdf
|
French | 135.5 KB | ||
| 2025-05-14 07:00 |
Nyxoah Reports First Quarter Financial and Operating Results
|
English | 49.0 KB | ||
| 2025-05-14 07:00 |
Q1 2025 financial report (Euronext) (ENG) - FINAL.pdf
|
English | 741.3 KB | ||
| 2025-05-14 07:00 |
Q1 2025 financial report (Euronext) (FR) - FINAL.pdf
|
French | 755.8 KB | ||
| 2025-05-14 07:00 |
ENGLISH_Q1 2025 Earnings PR_V3.pdf
|
English | 329.9 KB | ||
| 2025-05-14 07:00 |
FRENCH_Q1 2025 Earnings PR_V3.pdf
|
French | 351.9 KB | ||
| 2025-05-09 22:30 |
2025 05 09 PR Transparency notification 2025 05 (FMR LLC) (ENG).pdf
|
English | 175.0 KB | ||
| 2025-05-09 22:30 |
2025 05 09 PR Transparency notification 2025 05 (FMR LLC) (FR).pdf
|
French | 199.8 KB | ||
| 2025-05-09 07:00 |
DOC 13 - Statutory management report 2024 - ENG.pdf
|
English | 1.1 MB | ||
| 2025-05-09 07:00 |
DOC 15 - Auditor report - Statutory annual accounts (FR).pdf
|
French | 165.7 KB | ||
| 2025-05-09 07:00 |
DOC 14 - Statutory management report 2024 - FR.pdf
|
French | 1.3 MB | ||
| 2025-05-09 07:00 |
DOC 03 - Nyxoah - ASM 2025 - Attendance notification form - ENG FR.pdf
|
French | 195.2 KB |
Automate Your Workflow. Get a real-time feed of all Nyxoah SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nyxoah SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nyxoah SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-19 | Laurette Renard | Close relation | Sell | 5,000 | 39,000.00 EUR |
| 2024-09-05 | Hambrecht Jürgen | Board | Sell | 980,000 | 6,840,400.00 EUR |
| 2024-09-05 | JH Capital GmbH | Close relation | Buy | 980,000 | 6,840,400.00 EUR |
| 2024-01-25 | Tompkins Patrick | Executive member | Buy | 2,000 | 18,020.00 USD |
| 2023-12-28 | Onkelinx Bruno | Executive member | Buy | 470 | 2,035.10 EUR |
| 2023-08-18 | Moreau Loïc | Executive member | Buy | 6,427 | 48,416.52 EUR |
| 2023-08-14 | Moreau Loïc | Executive member | Buy | 3,800 | 28,697.60 EUR |
| 2023-08-11 | Moreau Loïc | Executive member | Buy | 3,000 | 21,957.60 EUR |
| 2023-07-04 | Wildman Ventures LLC | Board | Buy | 25,000 | N/A |
| 2023-07-02 | Gianello Pierre | Board | Buy | 25,000 | N/A |
Peer Companies
